Phase I |
Temoporfin (Foscan®) |
Surgery |
Non-small-cell lung cancer |
Completed |
2013–2019 |
NCT01854684 |
HPPH (Photochlor®) |
Surgery |
Head and neck cancer |
Completed |
2007–2018 |
NCT00470496 |
HPPH (Photochlor®) |
Surgery (laser therapy) |
Primary or invasive larynx cancer |
Completed |
2008–2018 |
NCT00675233 |
Motexafin lutetium |
Surgery |
Cervical intraepithelial neoplasia |
Terminated |
2003–2013 |
NCT00005808 |
- (Not marked) |
Surgery and radiosensitizer (etanidazole) |
Intraperitoneal or pleural cancer |
Terminated |
2003–2013 |
NCT00028782 |
Porfimer sodium (Photofrin®) |
Surgery |
Malignant mesothelioma |
Completed |
2003–2011 |
NCT00054002 |
Hematoporphyrin derivative |
Radiotherapy (brachytherapy) |
Lung cancer |
Completed |
2004–2013 |
NCT00014066 |
Hexaminolevulinate (HAL) |
Placebo ointment |
Cervical intraepithelial neoplasia |
Completed |
2010–2016 |
NCT01256424 |
Aminolaevulinic acid (ALA) |
Adjuvant (vitamin D3) |
Pre-malignant anal tumor |
Recruiting |
2016– |
NCT02698293 |
Porfimer sodium (Photofrin®) |
Chemotherapy (gemcitabine hydrochloride) |
Advanced pancreatic cancer |
Completed |
2013–2018 |
NCT01770132 |
Phase II |
Aminolaevulinic acid (ALA) |
Surgery |
Superficial non-melanoma skin cancer |
Completed |
2003–2013 |
NCT00002963 |
Porfimer sodium (Photofrin®) |
Surgery and chemotherapy |
Non-small-cell lung cancer |
Terminated |
2008–2020 |
NCT00601848 |
Porfimer sodium (Photofrin®) |
Surgery and chemotherapy (cisplatin) |
Malignant pleural mesothelioma |
Completed |
2016–2018 |
NCT02662504 |
Porfimer sodium (Photofrin®) |
Surgery and chemotherapy |
Malignant pleural mesothelioma |
Recruiting |
2014– |
NCT02153229 |
Hexaminolevulinate (HAL) |
Placebo |
Cervical intraepithelial neoplasia |
Terminated |
2008–2013 |
NCT00708942 |
Aminolaevulinic acid (ALA) |
Placebo |
Cervical intraepithelial neoplasia |
Completed |
2015–2019 |
NCT02631863 |
Phase II/III |
Methyl-5-aminolevulinate hydrochloride (Metvix®) |
Surgery (Ablative CO2 laser) |
Basal cell carcinoma |
Completed |
2010–2015 |
NCT01260987 |
Phase III |
Porfimer sodium (Photofrin®) |
Chemotherapy (gemcitabine/cisplatin) |
Cholangiocarcinoma |
Terminated |
2014–2019 |
NCT02082522 |
Porfimer sodium (Photofrin®) |
Chemotherapy (S-1) |
Cholangiocarcinoma |
Completed |
2009–2014 |
NCT00869635 |
Methyl-5-aminolevulinate hydrochloride (Metvix®) |
Placebo cream |
Basal cell carcinoma |
Completed |
2007–2010 |
NCT00472108 |
Methyl-5-aminolevulinate hydrochloride (Metvix®) |
Cryotherapy |
Basal cell carcinoma |
Completed |
2007–2010 |
NCT00469417 |